CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-11 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2015-06-11 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2015-06-11 | GARVEY JAMES M Director | Grant or award · Stock Option (right to buy) | +5,681 | 5,681 | ||
| 2015-06-10 | SVLSF IV, LLC 10% owner | Sale | −373,000 | $22.00 | $8.2M | 2,212,607 |
| 2015-06-10 | SVLSF IV, LLC 10% owner | Sale | −373,000 | $22.00 | $8.2M | 2,212,607 |
| 2015-06-10 | SVLSF IV, LLC 10% owner | Sale | −362,703 | $22.00 | $8.0M | 2,151,523 |
| 2015-06-10 | SVLSF IV, LLC 10% owner | Sale | −10,297 | $22.00 | $227K | 61,084 |
| 2015-06-10 | Versant Venture Capital III, L.P. 10% owner | Sale | −424,494 | $22.00 | $9.3M | 2,520,499 |
| 2015-06-10 | Versant Venture Capital III, L.P. 10% owner | Sale | −2,506 | $22.00 | $55K | 14,885 |
| 2015-06-10 | Warden Charles M Director | Sale | −424,494 | $22.00 | $9.3M | 2,520,499 |
| 2015-06-10 | Warden Charles M Director | Sale | −2,506 | $22.00 | $55K | 14,885 |
| 2015-05-13 | Sawhney Amarpreet President and CEO | Exercise or conversion | +51,491 | $1.35 | $70K | 538,733 |
| 2015-05-13 | Sawhney Amarpreet President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −51,491 | 58,357 | ||
| 2015-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +18,939 | $0.14 | $3K | 37,878 |
| 2015-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +5,681 | $0.96 | $5K | 43,559 |
| 2015-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (right to buy) | −18,939 | 0 | ||
| 2015-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (right to buy) | −5,681 | 0 | ||
| 2015-02-04 | Smith W Bradford CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2015-02-04 | Sawhney Amarpreet President and CEO | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2015-02-04 | Ankerud Eric | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 |
Page 22 of 27 · 522 trades